|
Match
|
Document |
Document Title |
|
|
US20110301057 |
IN SITU ORIENTED IMMOBILIZATION OF PROTEINS ON A SUPPORT
The present invention relates to a method of directing in situ oriented immobilization of a protein on a support. This method involves providing a support and contacting the support with a...
|
|
|
US20130089864 |
METHODS FOR CHARACTERIZING KIDNEY FUNCTION
Embodiments of the invention relate generally to methods of characterizing kidney function. In particular, several embodiments quantify kidney-associated marker RNA isolated from vesicles contained...
|
|
|
US20110143956 |
Diagnostic Kits and Methods for SCD or SCA Therapy Selection
Variations in certain genomic sequences useful as genetic markers of Sudden Cardiac Death (“SCD”) or Sudden Cardiac Arrest (“SCA”) risk are described. Novel diagnostic kits, DNA microar...
|
|
|
US20120064087 |
METHODS TO DIAGNOSE A REQUIRED REGULATION OF TROPHOBLAST INVASION
Methods are provided for the diagnosis and treatment of patients with increased risk of preeclampsia. The methods involve measuring levels of TGF-β3, receptors of cytokines of the TGfβ family, or H...
|
|
|
US20110076274 |
MATERIALS AND METHODS RELATING TO A G-PROTEIN COUPLED RECEPTOR
The present inventors demonstrate that the G-protein coupled receptor 55 (GPR55) is highly expressed in human aggressive breast cancer cells, and that the expression level may be correlated with...
|
|
|
US20130095543 |
METHOD FOR OBTAINING ETHANOL DURING FERMENTATION
The invention relates to a method for obtaining ethanol from a carbohydrate-containing raw substrate wherein the ethanol that is produced is separated during fermentation using a carrier gas. The...
|
|
|
US20130023459 |
Method for Preparing a Protein Emulsion
The present invention relates to a method for preparing a protein emulsion from bone material from which meat has been at least partially removed. The invention also relates to the protein emulsion...
|
|
|
US20100330013 |
AMADORIASES IN WASHING AND CLEANING PRODUCTS
Body care products, hair care products, shampoos, oral care, dental care and dental prosthesis care products, dental brace care products, cosmetics, therapeutics, washing agents, cleaning agents,...
|
|
|
US20120219585 |
INFLUENZA TREATMENT AND/OR CHARACTERIZATION, HUMAN-ADAPTED HA POLYPEPTIDES; VACCINES
The present invention provides, among other things, methods, reagents, and systems for the treatment, detection, analysis, and/or characterization of influenza infections.
|
|
|
US20100304419 |
METHOD FOR DETERMINING THE PROGNOSIS OF GASTRIC CANCER
The 14-3-3β protein is used herein as a tumor marker for prognosis in gastric cancer. The method comprises steps of providing a biological sample, qualifying the 14-3-3β protein level in the s...
|
|
|
US20110207213 |
Photoreactive Synthetic Regulator of Protein Function and Methods of Use Thereof
The present disclosure provides a photoreactive synthetic regulator of protein function. The present disclosure further provides a light-regulated polypeptide that includes a subject synthetic...
|
|
|
US20120083023 |
Microbial Oil Production From Biomass Hydrolysate By Oleaginous Yeast Strains
Oleaginous yeast strains are used to hydrolyze biomass (e.g. wheat straw) that has been pretreated using dilute acid, in order to produce lipids. The lipids may be used as feedstock for producing...
|
|
|
US20120214677 |
LUCIFERASE BIOSENSOR
A modified beetle luciferase protein which is an environmentally sensitive reporter protein is provided.
|
|
|
US20110189756 |
Method and composition for crystallizing G protein-coupled receptors
Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion...
|
|
|
US20110171728 |
Method and composition for crystallizing G protein-coupled receptors
Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion...
|
|
|
US20110009603 |
Method and composition for crystallizing G protein-coupled receptors
Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion...
|
|
|
US20100297085 |
Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers
A recombinant herpes simplex virus type-1 (HSV-1) has been constructed that carries a deletion of one of the two viral γ1 34.5 genes and other immediate early genes, which render the virus able to ...
|
|
|
US20110027267 |
Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
Fusion proteins having sequences that target specific moieties such as carbohydrates, lipids, and/or proteins that are associated with certain cell types and/or pathogens; and a sequence that...
|
|
|
US20110225674 |
Transformed plants or algae with highly expressed chloroplast protein BPG2
This invention provides a transformed plant or alga with increased chlorophyll, comprising an overexpressed foreign DNA which codes for a chloroplast protein BPG2 or a homologue thereof, and a...
|
|
|
US20120264164 |
LYMPH NODE SPECIMEN COLLECTION KIT AND METHOD OF PATHOLOGICAL ANALYSIS FOR LUNG CANCER DIAGNOSIS USING SUCH A KIT
A unique system for the correlation between removed lymph nodes for lung cancer diagnosis and pathological analysis thereof is provided. Such a system includes the removal of certain lymph nodes...
|
|
|
US20120231015 |
FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO
The invention relates to fragile X mental retardation protein (FMKP), compositions, and methods related thereto. In certain embodiments, the invention relates to treating a neurological disorder by...
|
|
|
US20120045800 |
Microalgae Biofuel Production System
A system for processing oil from algae is disclosed. Specifically, the system recycles byproducts of the process for use as nutrients during algae growth and oil production. The system includes a...
|
|
|
US20120301497 |
Plasmodium vivax Hybrid Circumsporozoite Protein and Vaccine
Described in this application is a synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain...
|
|
|
US20110189218 |
Plasmodium vivax hybrid circumsporozoite protein and vaccine
Described in this application is a synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain...
|
|
|
US20120114619 |
PROTEIN WITH PROMOTING EFFECTS FOR AXONAL GROWTH OF NEURONS OF CENTRAL NERVOUS SYSTEM
This invention comprises a polypeptide, a recombinant vector, a recombinant organism as well as RNA- and DNA-sequences. Furthermore, the use of polypeptides and recombinant vectors is described....
|
|
|
US20110212111 |
MHC II Associated Protein and Uses Thereof
The present invention provides a MHC II associated protein, MPYS, and methods for using the same. In particular, the MHC II-associated protein of the present invention mediates apoptosis and...
|
|
|
US20120171243 |
METHOD OF PREPARING LIVE VIRAL VACCINES BY GENETIC ENGINEERING OF VIRAL GENOME
Disclosed is an attenuation method of an influenza virus, that is, a reassortant virus and a preparation method thereof. The disclosed reassortant virus has, in a ratio of 6:2, genes encoding a...
|
|
|
US20110071123 |
Noninvasive Method for Measuring Histamine From Skin as an Objective Measurement of Itch
A method for measuring of histamine in an epidermis comprising applying an adhesive article to an epithelium of a mammal; allowing for adherence of epithelial cells to the adhesive article;...
|
|
|
US20100311099 |
USE OF HE4 FOR ASSESSMENT OF BREAST CANCERS
The disclosure relates to use of the HE4 marker to assess breast cancer in a patient. The disclosure also relates to using HE4 and other tumors markers for diagnosis, grading and staging of breast...
|
|
|
US20120041274 |
CANCER BIOMARKERS
Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.
|
|
|
US20130005026 |
CERVICAL CANCER SCREENING BY MOLECULAR DETECTION OF HUMAN PAPILLOMAVIRUS-INDUCED NEOPLASIA
Point-of-care tools for screening biological samples for markers associated with pathogenic microbial infections. In particular, devices and systems for screening cervical cells for the expression...
|
|
|
US20110313233 |
DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT
The present invention is in the field of treatment of diseased tissues, including cancerous tissues. In one embodiment, the present invention provides methods of identifying tissues that...
|
|
|
US20100305214 |
Use of a Monoterpene to Increase Tissue Repair
The invention relates to the use of a monoterpene to increase biological tissue repair, i.e. tissue regeneration or healing, the cosmetic use of a monoterpene to increase biological tissue repair...
|
|
|
US20120115198 |
METHODS FOR INCREASING THE PRODUCTION OF ETHANOL FROM MICROBIAL FERMENTATION
A stable continuous method for producing ethanol from anaerobic fermentation of a gaseous substrate containing at least one reducing gas in a liquid nutrient medium; supplying the gaseous substrate...
|
|
|
US20120088284 |
METHODS FOR INCREASING THE PRODUCTION OF ETHANOL FROM MICROBIAL FERMENTATION
A stable continuous method for producing ethanol from anaerobic fermentation of a gaseous substrate containing at least one reducing gas in a liquid nutrient medium; supplying the gaseous substrate...
|
|
|
US20120088283 |
METHODS FOR INCREASING THE PRODUCTION OF ETHANOL FROM MICROBIAL FERMENTATION
A stable continuous method for producing ethanol from anaerobic fermentation of a gaseous substrate containing at least one reducing gas in a liquid nutrient medium; supplying the gaseous substrate...
|
|
|
US20120088282 |
METHODS FOR INCREASING THE PRODUCTION OF ETHANOL FROM MICROBIAL FERMENTATION
A stable continuous method for producing ethanol from anaerobic fermentation of a gaseous substrate containing at least one reducing gas in a liquid nutrient medium; supplying the gaseous substrate...
|
|
|
US20120093884 |
NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE AS COMBINED VACCINE
The present invention relates to a combined norovirus and rotavirus vaccine for prevention of norovirus and rotavirus infection and/or viral-induced diarrheal and vomiting diseases in man. More...
|
|
|
US20120040389 |
METHOD FOR DEMONSTRATION OF A MOLECULAR EVENT IN A CELL BY MEANS OF FLUORESCENT MARKER PROTEINS
The invention relates to a method for demonstration of the occurrence of a molecular event, particularly in a cell, characterised by the detection of the ‘solubilisation’ of a fixed protein mar...
|
|
|
US20120171144 |
METHODS OF TREATING, REDUCING AND INHIBITING THE APPEARANCE OF AGEING IN THE SKIN
Methods of treating, reducing and inhibiting the appearance of ageing in the skin are provided. Also provided are uses and methods of maintaining a youthful appearance, reducing an appearance of...
|
|
|
US20110287963 |
SYSTEM USEFUL FOR REPORTING PROTEIN-PROTEIN INTERACTIONS IN THE BACTERIAL PERIPLASM
One aspect of the present invention relates to a reporter system for detection of protein-protein interactions in the periplasm of a prokaryotic host cell. The reporter system includes a first...
|
|
|
US20110150775 |
GENOMIC APPROACHES TO FETAL TREATMENT AND DIAGNOSIS
The present invention provides systems for developing and/or testing therapies for prenatal diseases and conditions including Down Syndrome. The present invention also provides diagnostic methods...
|
|
|
US20100297108 |
METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS
A novel treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed...
|
|
|
US20120070826 |
LAFORA'S DISEASE GENE
A novel gene (EPM2B) that is mutated in humans and dogs with Lafora's disease is described.
|
|
|
US20120117673 |
GENETIC ENCRYPTION
The present invention relates to a method to engineer either the genome of a genetically modified organism, other bioengineered reagent, or in vitro translation system for protein synthesis from...
|
|
|
US20130065775 |
Methods for diagnosing skin diseases
The present invention relates to methods for diagnosing cornification disorders and metabolic diseases. More specifically, the present invention relates to an in vitro method for diagnosing and/or...
|
|
|
US20120028254 |
SNP Marker of Breast and Ovarian Cancer Risk
The invention provides methods for predicting an increased risk or probability of developing breast or ovarian cancer in a patient based upon the patient's KRAS-Variant and BRCA status.
|
|
|
US20120201940 |
METHOD OF MAKING AN ENHANCED NATURAL SWEETENER
A method of making a natural sweetening composition comprising the steps of (a) steam stripping a crude mixture of at least one plant based natural high intensity sweetening compound; and (b) at...
|
|
|
US20120196372 |
Methods for Reducing Gluconoylation of Proteins
The present invention relates to methods of preventing glyconoylation of polypeptides produced in micororganisms.
|
|
|
US20120039908 |
Control of Protein Glycosylation and Compositions and Methods Relating Thereto
The invention relates to novel methods for controlling the glycosylation of a protein and the protein produced thereby. An exemplary method of the invention comprises producing a protein comprising...
|